IDO ‐1 inhibition improves outcome after fluid percussion injury in adult male rats
Journal of Neuroscience Research · 2024
DOI: 10.1002/jnr.25338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroscience Research, 2024. Verfasst von Marawan Sadek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Krembil Research Institute, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Brain Injuries, Traumatic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The enzyme indoleamine 2,3 dioxygenase 1 (IDO1) catalyzes the rate‐limiting step in the kynurenine pathway (KP) which produces both neuroprotective and neurotoxic metabolites. Neuroinflammatory signals produced as a result of pathological conditions can increase production of IDO1 and boost its enzymatic capacity. IDO1 and the KP have been implicated in behavioral recovery after human traumatic brain injury (TBI), but their roles in experimental models of TBI are for the most part unknown. We hypothesized there is an increase in KP activity in the fluid percussion injury (FPI) model of TBI, and that administration of an IDO1 inhibitor will improve neurological recovery. In this study, adult male Sprague Dawley rats were subjected to FPI or sham injury and received twice‐daily oral administration of the IDO1 inhibitor PF‐06840003 (100 mg/kg) or vehicle control. FPI resulted in a significant increase in KP activity, as demonstrated by an increased ratio of kynurenine: tryptophan, in the perilesional neocortex and ipsilateral hippocampus 3 days postinjury (DPI), which normalized by 7 DPI. The increase in KP activity was prevented by PF‐06840003. IDO1 inhibition also improved memory performance as assessed in the Barnes maze and anxiety behaviors as assessed in open field testing in the first 28 DPI. These results suggest increased KP activity after FPI may mediate neurological dysfunction, and IDO1 inhibition should be further investigated as a potential therapeutic target to improve recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
- Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
- Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Aylin Y Reid
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Sadek, M., Stover, K. R., Liu, X., Reed, M. A., Weaver, D. F., & Reid, A. Y. (2024). IDO ‐1 inhibition improves outcome after fluid percussion injury in adult male rats. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.25338
Vancouver
Sadek M, Stover KR, Liu X, Reed MA, Weaver DF, Reid AY. IDO ‐1 inhibition improves outcome after fluid percussion injury in adult male rats. Journal of Neuroscience Research. 2024. doi:10.1002/jnr.25338
BibTeX
@article{Sadek2024,
author = {Sadek, Marawan and Stover, Kurt R and Liu, Xiaojing and Reed, Mark A and Weaver, Donald F and Reid, Aylin Y},
title = {IDO ‐1 inhibition improves outcome after fluid percussion injury in adult male rats},
journal = {Journal of Neuroscience Research},
year = {2024},
doi = {10.1002/jnr.25338}
}
EUVIMED